These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
386 related articles for article (PubMed ID: 34000235)
41. Extracorporeal Life Support (ECLS): A Review and Focus on Considerations for COVID-19. Tabatabai A; Galvagno SM; O'Connor JV; Scalea TM; Deatrick KB Shock; 2021 Jun; 55(6):742-751. PubMed ID: 33393754 [TBL] [Abstract][Full Text] [Related]
42. Extracorporeal membrane oxygenation for critically ill patients with coronavirus-associated disease 2019: an updated perspective of the European experience. Marullo AG; Cavarretta E; Biondi Zoccai G; Mancone M; Peruzzi M; Piscioneri F; Sartini P; Versaci F; Morelli A; Miraldi F; Frati G Minerva Cardioangiol; 2020 Oct; 68(5):368-372. PubMed ID: 32336080 [TBL] [Abstract][Full Text] [Related]
43. Use of ECMO in Patients With Coronavirus Disease 2019: Does the Evidence Suffice? Alom S; Haiduc AA; Melamed N; Axiaq A; Harky A J Cardiothorac Vasc Anesth; 2021 Apr; 35(4):1256-1262. PubMed ID: 32891520 [No Abstract] [Full Text] [Related]
44. The need to define "who" rather than "if" for ECMO in COVID-19. Whebell S; Zhang J; Lewis R; Berry M; Ledot S; Retter A; Camporota L Intensive Care Med; 2022 Jul; 48(7):979-980. PubMed ID: 35579687 [No Abstract] [Full Text] [Related]
45. Blood transfusion strategies and ECMO during the COVID-19 pandemic - Authors' reply. Ramanathan K; MacLaren G; Combes A; Brodie D; Shekar K Lancet Respir Med; 2020 May; 8(5):e41. PubMed ID: 32305077 [No Abstract] [Full Text] [Related]
46. Cytokine adsorption and ECMO in patients with COVID-19. Rybalko A; Voronin AV; Karpun NA Lancet Respir Med; 2021 Aug; 9(8):e69-e70. PubMed ID: 34242579 [No Abstract] [Full Text] [Related]
47. Extracorporeal Membrane Oxygenation for Coronavirus Disease 2019-Induced Acute Respiratory Distress Syndrome: A Multicenter Descriptive Study. Yang X; Cai S; Luo Y; Zhu F; Hu M; Zhao Y; Zheng R; Li X; Hu B; Peng Z Crit Care Med; 2020 Sep; 48(9):1289-1295. PubMed ID: 32427613 [TBL] [Abstract][Full Text] [Related]
49. Coagulopathy monitoring and anticoagulation management in COVID-19 patients on ECMO: Advantages of a heparin anti-Xa-based titration strategy. Rhoades R; Leong R; Kopenitz J; Thoma B; McDermott L; Dovidio J; Barletti S; Gong JZ; Massey HT; McKenzie SE; Rame JE; Al-Rawas N Thromb Res; 2021 Jul; 203():1-4. PubMed ID: 33894473 [No Abstract] [Full Text] [Related]
50. COVID-19, ECMO, and respiratory infection: A new triad? Zaidi S; Nguyen D; Harky A J Card Surg; 2022 Nov; 37(11):3619-3622. PubMed ID: 36073142 [No Abstract] [Full Text] [Related]
51. Increased mortality in patients with COVID-19 receiving extracorporeal respiratory support during the second wave of the pandemic. Riera J; Roncon-Albuquerque R; Fuset MP; Alcántara S; Blanco-Schweizer P; Intensive Care Med; 2021 Dec; 47(12):1490-1493. PubMed ID: 34499190 [No Abstract] [Full Text] [Related]
52. Essential Topics in the Management of Venovenous Extracorporeal Membrane Oxygenation in COVID-19 Acute Respiratory Distress Syndrome. Ali Usman A; Gutsche J J Cardiothorac Vasc Anesth; 2021 Sep; 35(9):2552-2555. PubMed ID: 34088550 [No Abstract] [Full Text] [Related]
53. Extracorporeal Membrane Oxygenation in Acute Respiratory Distress Syndrome: How Do We Expand Capacity in the COVID-19 Era? Peeler A; Gleason KT; Cho SM; Davidson PM Heart Lung Circ; 2021 May; 30(5):623-625. PubMed ID: 33707137 [No Abstract] [Full Text] [Related]
54. [Comparison of extracorporeal membrane oxygenation applicated in critical patients with COVID-19 and novel influenza A (H1N1) virus pneumonia]. Tang X; Pu L; Zhang JY; Chao LS; Wang R; Guo D; Qi HS; Wang WS; Yin FZ; Li XY; Li Y; Yuan X; Du ZT; Xu B; Liu JY; Yan XX; Sun B Zhonghua Yi Xue Za Zhi; 2021 Mar; 101(8):579-585. PubMed ID: 33663189 [No Abstract] [Full Text] [Related]
55. [Study on the extracorporeal membrane oxygenation inter-hospital transport during coronavirus disease 2019 epidemic: based on the transport experience of 6 cases of severe H1N1 influenza virus pneumonia on extracorporeal membrane oxygenation]. Xu Q; Jiang X; Wang T; Zhou Q; Wang J; Zhang P; Yang S; Yan H; Tao X; Lu W Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Apr; 32(4):430-434. PubMed ID: 32527347 [TBL] [Abstract][Full Text] [Related]
56. A Patient with COVID-19 Treated with ECMO for 26 Days. Zhang C; Shi B; Ma H; Dong N J Coll Physicians Surg Pak; 2020 Oct; 30(10):171-173. PubMed ID: 33291198 [TBL] [Abstract][Full Text] [Related]
57. Coronavirus Epidemic and Extracorporeal Therapies in Intensive Care: si vis pacem para bellum. Ronco C; Reis T; De Rosa S Blood Purif; 2020; 49(3):255-258. PubMed ID: 32172242 [No Abstract] [Full Text] [Related]
58. Overcoming bleeding events related to extracorporeal membrane oxygenation in COVID-19. Asakura H; Ogawa H Lancet Respir Med; 2020 Dec; 8(12):e87-e88. PubMed ID: 33129422 [No Abstract] [Full Text] [Related]
59. ECMO in COVID-19: Continued Variable Outcomes. Emerson D; Sharifpour M Ann Thorac Surg; 2022 Jul; 114(1):75-76. PubMed ID: 35331708 [No Abstract] [Full Text] [Related]
60. Real-World Outcomes for ECMO in COVID-19. Nurok M; Brodie D Ann Thorac Surg; 2022 Jul; 114(1):68-69. PubMed ID: 35196522 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]